AAAAAA

   
Results: 1-11 |
Results: 11
Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males
Authors: Arruda, VR Fields, PA Milner, R Wainwright, L De Miguel, MP Donovan, PJ Herzog, RW Nichols, TC Biegel, JA Razavi, M Dake, M Huff, D Flake, AW Couto, L Kay, MA High, KA
Citation: Vr. Arruda et al., Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males, MOL THER, 4(6), 2001, pp. 586-592
Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation
Authors: Herzog, RW Mount, JD Arruda, VR High, KA Lothrop, CD
Citation: Rw. Herzog et al., Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation, MOL THER, 4(3), 2001, pp. 192-200
Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9
Authors: Fields, PA Arruda, VR Armstrong, E Chu, K Mingozzi, F Hagstrom, JN Herzog, RW High, KA
Citation: Pa. Fields et al., Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9, MOL THER, 4(3), 2001, pp. 201-210
Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice
Authors: Fields, PA Armstrong, E Hagstrom, JN Arruda, VR Murphy, ML Farrell, JP High, KA Herzog, RW
Citation: Pa. Fields et al., Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice, GENE THER, 8(5), 2001, pp. 354-361
Posttranslational modifications of recombinant myotube-synthesized human factor IX
Authors: Arruda, VR Hagstrom, JN Deitch, J Heiman-Patterson, T Camire, RM Chu, K Fields, PA Herzog, RW Couto, LB Larson, PJ High, KA
Citation: Vr. Arruda et al., Posttranslational modifications of recombinant myotube-synthesized human factor IX, BLOOD, 97(1), 2001, pp. 130-138
Role of vector in activation of T cell subsets in immune responses againstthe secreted transgene product factor IX
Authors: Fields, PA Kowalczyk, DW Arruda, VR Armstrong, E McCleland, ML Hagstrom, JN Pasi, KJ Ertl, HCJ Herzog, RW High, KA
Citation: Pa. Fields et al., Role of vector in activation of T cell subsets in immune responses againstthe secreted transgene product factor IX, MOL THER, 1(3), 2000, pp. 225-235
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
Authors: Kay, MA Manno, CS Ragni, MV Larson, PJ Couto, LB McClelland, A Glader, B Chew, AJ Tai, SJ Herzog, RW Arruda, V Johnson, F Scallan, C Skarsgard, E Flake, AW High, KA
Citation: Ma. Kay et al., Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector, NAT GENET, 24(3), 2000, pp. 257-261
Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony
Authors: Herzog, RW Arruda, VR Fisher, TH Read, MS Nichols, TC High, KA
Citation: Rw. Herzog et al., Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony, THROMB HAEM, 84(2), 2000, pp. 352-354
Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter
Authors: Hagstrom, JN Couto, LB Scallan, C Burton, M McCleland, ML Fields, PA Arruda, VR Herzog, RW High, KA
Citation: Jn. Hagstrom et al., Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter, BLOOD, 95(8), 2000, pp. 2536-2542
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
Authors: Herzog, RW Yang, EY Couto, LB Hagstrom, JN Elwell, D Fields, PA Burton, M Bellinger, DA Read, MS Brinkhous, KM Podsakoff, GM Nichols, TC Kurtzman, GJ High, KA
Citation: Rw. Herzog et al., Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector, NAT MED, 5(1), 1999, pp. 56-63
Adeno-associated virus-mediated gene transfer of factor IX for treatment of hemophilia B by gene therapy
Authors: Herzog, RW High, KA
Citation: Rw. Herzog et Ka. High, Adeno-associated virus-mediated gene transfer of factor IX for treatment of hemophilia B by gene therapy, THROMB HAEM, 82(2), 1999, pp. 540-546
Risultati: 1-11 |